Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,846 | 91 | 99.8% |
| Education | $3.75 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $258.54 | 10 | $0 (2020) |
| ABBVIE INC. | $205.70 | 3 | $0 (2023) |
| PFIZER INC. | $142.72 | 7 | $0 (2020) |
| GlaxoSmithKline, LLC. | $135.57 | 10 | $0 (2019) |
| Abbott Laboratories | $122.51 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $117.58 | 2 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $112.61 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $109.92 | 9 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $50.45 | 4 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $49.20 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $321.75 | 3 | Abbott Laboratories ($122.51) |
| 2022 | $203.88 | 2 | Biohaven Pharmaceutical Holding Company Ltd. ($112.61) |
| 2021 | $18.77 | 1 | AbbVie Inc. ($18.77) |
| 2020 | $97.96 | 7 | Novartis Pharmaceuticals Corporation ($29.23) |
| 2019 | $658.14 | 37 | Novartis Pharmaceuticals Corporation ($217.27) |
| 2018 | $365.26 | 28 | GlaxoSmithKline, LLC. ($46.96) |
| 2017 | $184.26 | 14 | GlaxoSmithKline, LLC. ($51.94) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $103.58 | General |
| Category: Biological | ||||||
| 06/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $122.51 | General |
| Category: Diabetes Care | ||||||
| 05/09/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $95.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $91.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $112.61 | General |
| Category: PRIMARY CARE | ||||||
| 03/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: Cardiovascular | ||||||
| 02/24/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROLOGY | ||||||
| 02/17/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/05/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/27/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/21/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: VACCINES | ||||||
| 01/14/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY XR | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: DIABETES | ||||||
| 11/20/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: PAIN | ||||||
| 11/14/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Endocrinology | ||||||
| 11/12/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/07/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $71.67 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/06/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: DIABETES | ||||||
| 11/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: DIABETES | ||||||
| 10/31/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: DIABETES | ||||||
| 10/24/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.68 | General |
| Category: Cardiovascular | ||||||
| 10/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,246 | 2,044 | $291,612 | $114,886 |
| 2022 | 14 | 1,164 | 1,905 | $287,468 | $109,638 |
| 2021 | 15 | 1,313 | 2,080 | $287,979 | $117,971 |
| 2020 | 14 | 984 | 1,580 | $203,227 | $75,919 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 258 | 550 | $133,372 | $44,423 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 224 | 224 | $66,976 | $27,639 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 153 | $26,251 | $8,851 | 33.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 31 | $12,373 | $8,443 | 68.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 83 | 83 | $7,911 | $5,885 | 74.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 274 | 535 | $4,590 | $4,368 | 95.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 22 | $10,340 | $3,412 | 33.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 21 | 21 | $8,022 | $3,170 | 39.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 88 | 88 | $5,074 | $2,580 | 50.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 13 | 14 | $3,718 | $1,799 | 48.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,213 | $1,588 | 37.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,678 | $889.80 | 53.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 16 | $4,069 | $826.23 | 20.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 13 | 14 | $1,162 | $553.70 | 47.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 15 | $795.00 | $238.84 | 30.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 224 | $793.06 | $172.86 | 21.8% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 11 | 12 | $276.00 | $45.83 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 580 | $141,520 | $47,004 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 210 | 210 | $65,310 | $26,464 | 40.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 30 | 30 | $14,010 | $8,364 | 59.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 105 | $18,060 | $5,823 | 32.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 82 | 82 | $6,970 | $5,614 | 80.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 26 | 26 | $10,348 | $4,211 | 40.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 20 | 20 | $9,760 | $3,174 | 32.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 17 | 17 | $6,766 | $2,754 | 40.7% |
About Taariq Goder
Taariq Goder is a Family Medicine healthcare provider based in Peoria, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1437565561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Taariq Goder has received a total of $1,850 in payments from pharmaceutical and medical device companies, with $321.75 received in 2023. These payments were reported across 92 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($1,846).
As a Medicare-enrolled provider, Goder has provided services to 4,707 Medicare beneficiaries, totaling 7,609 services with total Medicare billing of $418,415. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Peoria, IL
- Active Since 07/09/2014
- Last Updated 07/09/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437565561
Products in Payments
- ENTRESTO (Drug) $244.06
- FREESTYLE LIBRE 3 (Device) $122.51
- NURTEC ODT (Drug) $112.61
- Veozah (Drug) $103.58
- QULIPTA (Drug) $95.66
- UBRELVY (Drug) $91.27
- ANORO (Drug) $77.07
- COLOGUARD (Device) $71.67
- Livalo (Drug) $50.45
- SUNOSI (Drug) $48.86
- JARDIANCE (Drug) $48.55
- CHANTIX (Drug) $39.83
- TRADJENTA (Drug) $39.68
- TOUJEO (Drug) $36.34
- ADVAIR (Drug) $35.28
- VRAYLAR (Drug) $33.33
- Prolastin-C (Biological) $30.53
- UTIBRON (Drug) $29.34
- ELIQUIS (Drug) $26.01
- XARELTO (Drug) $25.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Peoria
David Trachtenbarg, Md, MD
Family Medicine — Payments: $71,674
Nimisha Shah, M.d, M.D
Family Medicine — Payments: $17,013
David Nye, Do, DO
Family Medicine — Payments: $14,749
Arvind Mahadevan, M.d, M.D
Family Medicine — Payments: $12,144
Darren Conklin, Do, DO
Family Medicine — Payments: $9,838
Andrew Cusack, Do, DO
Family Medicine — Payments: $9,147